BIO 2017: The success story of OmniRat

20-06-2017

BIO 2017: The success story of OmniRat

fotografixx / iStockphoto.com

The creator of OmniRat, the first human monoclonal antibody technology based on rats, outlined the success story of the project yesterday at the 2017 BIO International Convention.


BIO 2017, OmniRat, patent, patentability, European Patent Office, licensing, Ligand Pharmaceuticals, antibodies, genetic engineering,

LSIPR